Table 1.
Demographic and clinical characteristics of study patients (N=250)
| Characteristic | No body morphology abnormalities N=46 |
Mild lipohypertrophy N=106 |
Mild lipoatrophy N=65 |
Moderate-to-severe lipohypertrophy N=22 |
Moderate-to-severe lipoatrophy N=11 |
p Value |
|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | N (%) | ||
| Sex | ||||||
| Male | 41 (89) | 93 (88) | 56 (86) | 15 (68) | 10 (91) | |
| Female | 5 (11) | 13 (12) | 9 (14) | 7 (32) | 1 (9) | 0.15 |
| Race | ||||||
| White | 30 (65) | 68 (64) | 46 (71) | 14 (64) | 10 (91) | |
| Black | 11 (24) | 23 (22) | 13 (20) | 8 (36) | 1 (9) | |
| Hispanic | 4 (9) | 9 (8) | 4 (6) | 0 | 0 | |
| Other/Unknown | 1 (2) | 6 (6) | 2 (3) | 0 | 0 | 0.6 |
| Age (years) | ||||||
| < 30 | 9 (20) | 4 (4) | 6 (9) | 0 | 0 | |
| 30-39 | 14 (30) | 34 (32) | 13 (20) | 7 (32) | 2 (18) | |
| 40-49 | 18 (39) | 43 (41) | 26 (40) | 12 (55) | 6 (55) | |
| ≥50 | 5 (11) | 25 (24) | 20 (31) | 3 (14) | 3 (27) | 0.03 |
| Risk factor for HIV transmission | ||||||
| Male sex-with-male | 28 (61) | 58 (55) | 36 (55) | 12 (55) | 6 (55) | |
| Injection drug use | 12 (26) | 30 (28) | 14 (22) | 3 (14) | 3 (27) | |
| Heterosexual | 6 (13) | 17 (16) | 10 (15) | 6 (27) | 1 (9) | |
| Other/unknown | 0 | 1 (1) | 5 (8) | 1 (5) | 1 (9) | 0.4 |
| Current CD4R+cell count (cells/mm3) | ||||||
| 0-200 | 12 (26) | 22 (21) | 15 (23) | 2 (9) | 6 (55) | |
| 201-350 | 16 (35) | 27 (25) | 12 (18) | 7 (32) | 3 (27) | |
| 351 or greater | 18 (39) | 57 (54) | 38 (58) | 13 (59) | 2 (18) | 0.06 |
| Currently receiving HAART | ||||||
| Yes | 27 (59) | 79 (75) | 54 (83) | 21 (95) | 9 (82) | |
| No | 19 (41) | 27 (25) | 11 (17) | 1 (5) | 2 (18) | 0.007 |